LOXENTIA

This brand name is authorized in Finland, Ireland

Active ingredients

The drug LOXENTIA contains one active pharmaceutical ingredient (API):

1 Duloxetine UNII 9044SC542W - DULOXETINE HYDROCHLORIDE

Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors. Read about Duloxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOXENTIA Hard gastro-resistant capsule	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX21	Duloxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 199099, 454335
Country: IE	Health Products Regulatory Authority	Identifier(s): 36872, 36873